Live
- Lathi-charge on students in Hazaribagh kicks up political row; demand for CBI probe grows
- India’s growth to rebound to 7 pc in 2025-26: Report
- Delhi has decided to elect BJP CM, oust AAP govt: Harsh Malhotra
- Congress-led UDF winning streak continues in Kerala, ruling CPI-M-led Left suffers reversal
- The Key Players Behind IPL: Discover the Franchise Owners and Their Success Stories
- Harris and Gill join Sydney Thunders for WBBL 11
- PKL Season 11: Bengal Warriorz coach Surve aims for maximum points to secure playoff spot
- Manchu Vishnu Warns Media Over Family Controversy, Mohan Babu Incident
- Atul Subhash’s Suicide Sparks Outrage; Estranged Wife, Judge Accused of Harassment
- Malaria cases, deaths in India decline by 69pc between 2017-2023: WHO
Sputnik V soft launched in over 50 cities in India: Dr Reddy s
Sputnik V soft launched in over 50 cities in India
Dr. Reddys Laboratories Ltd, which soft-launched Russia's COVID-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country.
Dr. Reddys Laboratories Ltd, which soft-launched Russia's COVID-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country.
In a tweet on Monday night, the city-based drugmaker said it will strengthen the commercial rollout of Sputnik V in the coming weeks.
''Starting initially in Hyderabad today, the soft launch rollout of Sputnik V has scaled up speedily and reached cities and towns all over India- including but not limited to Hyderabad, Vizag, Bengaluru, Mumbai, Navi Mumbai, Kolkata, Delhi, NCR, Chennai, Miryalaguda, Vijayawada, Baddi, Kolhapur, Kochi, Raipur, Chandigarh, Pune, Nagpur, Nashik it said in the tweet.
Recently, Dr. Reddy's received nearly three million doses ofSputnikV from Russian Direct Investment Fund with which it has a pact to sell 125 million people doses (250 million vials) in India.
The Indian drug regulator has granted permission for restricted emergency use of SputnikV, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.
Dr. Reddys has partnered with major hospitals across the country for this purpose all of whom have successfully administered Sputnik V in India including ongoing commercial rollouts to the public, the company added.
